首页> 外文会议>International Symposium on Regulation of Enzyme Activity and Synthesis in Normal and Neoplastic Tissues >A comprehensive model for the allosteric regulation of Class la ribonucleotide reductases
【24h】

A comprehensive model for the allosteric regulation of Class la ribonucleotide reductases

机译:La Ribon核苷酸还原酶的变构调节综合模型

获取原文

摘要

Reduction of NDPs by murine ribonucleotidc reductase (mRR) requires catalytic (mRl) and free radical-containing (mR2) subunits and is regulated by nucleoside triphosphate allosteric effectors. Here we present a comprehensive and quantitative model forallosteric control of mRR enzymatic activity based on molecular mass, ligand binding and enzyme activity studies. In this model, nucleotide binding to the specificity site (s-site) drives formation of R1_2, ATP or dATP binding to the adenine-specific site (a-site) results in formation of tetramer Rl_(4a) which isomehzes to the more stable R1_(4b), and ATP binding to the newly described hexamerization site (h-site) drives formation of R1_6. The R2_2 complexes of R1_2, R1_(4a), and R1_6 are enzymaticallyactive, whereas the R2_2 complexes of R1_(4b) are not. Thus, a key aspect of the down regulation of RR enzymatic activity is the ability of dATP or ATP binding to the a-site to drive not only Rl letramer formation, but also the conversion of Rl_(4a) toR1_(4b) and it is ATP binding to the h-site which accounts for its activating properties at high (>lmM) concentration. The D57N variant of mRl is not inhibited by dATP because of a block in the formation of R1_(4b), but not of Rl_(4a) or Rl_6. The new model revises and improves upon an earlier phenomenological model (Thelander and Reichard 1979) (the 'RT' model) which ignores aggregation state changes and the h-site, and incorrectly rationalizes ATP activation vs. dATP inhibition as reflecting differentfunctional consequences of ATP vs. dATP binding to the a-site. Our results suggest that the R1_6R2_6 heterohexamer is the major active form of the enzyme in mammalian cell cytoplasm, where [ATP] is the primary modulator of enzyme activity, coupling therate of DNA biosynthesis with the energetic state of the cell. However, it remains possible that the helerodimer formed by complexation of R1_2 with p53R2 is the active form of the enzyme in the nucleus. Using the crystal structure of the Escherichia coli Rl hexamer as a model for the mRl hexamer, a scheme is presented that rationalizes the slow isomerization of the letramer form and suggests an explanation for the low enzymatic activity of tetramers complexed with R2. The similar specific activities of R1_2R2_2 and R1_6R2_6 are inconsistent with a proposed model for R2_2 docking with R1_2 (Uhlin and Eklund. 1994) and an alternative model is proposed.
机译:通过鼠核糖核苷酸还原酶(MRR)的降低NDPS需要催化(MRL)和含有自由基的(MR2)亚基,并受核苷三磷酸血糖雌激素效应的调节。在这里,我们基于分子量,配体结合和酶活性研究,对MRR酶活性的全面和定量模型进行血栓性控制。在该模型中,与特异性位点(S-位点)的核苷酸结合在腺嘌呤特异性位点(A-位点)的形成R1_2,ATP或DATP结合的形成结果,导致四聚体RL_(4a)的形成更稳定R1_(4B)和ATP与新描述的六种六种六种六种六种六种六种地位)驱动R1_6的形成。 R1_2,R1_(4a)和R1_6的R2_2复合物是酶促的,而R1_(4B)的R2_2复合物不是。因此,RR酶活性的下调调节的关键方面是DATP或ATP结合到A-位点的能力不仅可以驱动RL Letramer的形成,而且还可以转换R1_(4A)TOR1_(4B)的转换ATP与H型位点结合,其在高(> LMM)浓度下占其激活性质。由于R1_(4B)的形成,但不具有RL_(4A)或RL_6,因此MRL的D57N变体不会被DATP抑制。新的模型改变并改善了较早的现象学模型(Thelander和Reichard 1979)('RT'模型),其忽略聚集状态变化和H现场,并且错误地合理化了ATP激活与DATP抑制作用,反映了ATP的不同功能后果与DATP绑定到A现场。我们的研究结果表明,R1_6R2_6杂化物是哺乳动物细胞细胞质中酶的主要活性形式,其中[ATP]是酶活性的主要调节剂,与细胞的能量状态偶联DNA生物合成级。然而,通过具有P53R2的R1_2的络合形成的昏暗可能是核心中的活性形式。使用大肠杆菌RL六聚醚的晶体结构作为MRL六氧聚醚的模型,提出了一种方案,其合理化了LetRamer形式的缓慢异构化,并表明对络合物络合的四聚体的低酶活性的解释。 R1_2R2_2和R1_6R2_6的类似特定活动与R2_2与R1_2(Uhlin和Eklund.1994)的R2_2对接的建议模型不一致。提出了一种替代模型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号